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Introduction: Anaplastic large cell lymphoma is a subset of non-Hodgkin lymphoma and an unusual disease in children.
Case Presentation: Herein we have reported a 7- year- old girl with a large necrotic skin ulcer on the chest caused by systemic form of 
anaplastic large-cell lymphoma and simultaneous active toxoplasmosis diagnosed by PCR on lymph node specimen. There were few 
reports showing a role for toxoplasma infection to cause some malignancies such as lymphoma in adults.
Conclusions: Based to our knowledge, this has been the first report of simultaneous systemic anaplastic large cell lymphoma and active 
toxoplasmosis, documented by positive PCR on tissue biopsy in a child. This case report has suggested more attention to the accompanying Toxoplasma gondii infection as a probable cause of some types of lymphomas.
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1. Introduction
Anaplastic large cell lymphoma (ALCL) or Ki-1 lympho-
ma is a subset of non-Hodgkin lymphoma and an unusu-
al disease in children accounting for 10% - 15% of all child-
hood non-Hodgkin lymphomas (1-3).
This disease is a T or null cell lymphoma characterized 
by proliferation of pleomorphic large neoplastic lym-
phoid cells which express the CD30 antigen (Ki-1 antigen) 
(1-4). There are few studies about the role of Toxoplasma gondii infection in the pathogenesis of lymphoma in 
adults (5).
Herein we have reported a 7-year-old girl with a large ne-
crotic ulcer, simultaneous active toxoplasmosis and final 
diagnosis of systemic form of ALCL. Based to our knowl-
edge, this is the first report of simultaneity of ALCL and 
active toxoplasmosis in a child.
2. Case Presentation
A 7-year-old girl was referred to Mofid Children’s Hospi-
tal with a large necrotic ulcer on his left upper chest, and 
generalized lymphadenopathy since two months ago 
(Figure 1).
The ulcer was begun with a small pruritic papule on the 
left upper chest, enlarged and extended to the neck, and 
then ulcerated.
She had a history of toxoplasmosis presenting with cer-
vical lymphadenopathy, and positive IgM and IgG anti-
toxoplasma antibodies, at least 10 months before this 
ulcer appearance. An excisional biopsy was performed at 
that time, with result of preserved nodal architecture, fol-
licular hyperplasia and no malignant cells and positive 
PCR for Toxoplasma gondii infection, so, she underwent 
following up until the skin ulcer appeared, and then, she 
was referred for more extensive work up.
On physical examination she had a large necrotic ulcer 
(20 × 10 Cm) with a noma appearance on the chest, and 
a hyperpigmented plaque (2 × 1 cm) on the abdomen, 
along with generalized lymphadenopathy and mild 
splenomegaly.
After debridement of the chest wall ulcer and biopsies 
of abdominal skin and cervical lymph node, she was 
treated with ceftriaxone and clindamycin.
Several aerobic and anaerobic microorganisms such as Staphylococcus saprophyticus, Lactobacillus spp., entero-
cocci spp., Staphylococcus aureus and Peptococus niger 
were isolated from the ulcer culture.
Further investigation showed normal bone survey and 
bone marrow aspiration.
Thoracic computed tomography (CT) without contrast 
revealed a large lobulated mass in the left anterior chest 
wall, with extension to the axillary area and several 
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Figure 1. A large Necrotic Ulcer (20 × 10 Cm) on the Left Upper Chest of the 
Patient With a Normal Appearance
Figure 2. Cohesive Sheets of Relatively Monomorphic Atypical Cells With 
Round Vesicular Nuclei (H & E, × 400)
Figure 3. Positive Immunostaining of Perivascular Neoplastic Cells for 
ALK (× 400)
cervical and left supra clavicular lymphadenopathies. 
(The CT scan was not available in this article). Abdominal 
and pelvic CT scan revealed mildly enlarged spleen and 
para-aortic lymphadenopathies.
CT scan of the neck showed multiple extensive adenopa-
thies predominantly in the left side of the neck and sig-
nificant soft tissue swelling of the lower neck and chest 
wall. Brain CT scan was normal.
Routine laboratory tests were within normal ranges. 
Specific anti-toxoplasma antibody was detected by in-
direct immunofluorescent assay (IFA), shown a titre of 
1:6400.
HIV test was negative. Biopsies of cervical lymph node, 
abdominal skin plaque and chest wall ulcer debridement 
were compatible with anaplastic large cell lymphoma 
(Figure 2). Immunohistochemical staining of cervical 
lymph node biopsy revealed tumour cells to be positive 
for leukocyte common antigen (LCA), ALK, CD30, CD3 and 
weakly positive for epithelial membrane antigen (EMA) 
(Figure 3). The second time PCR for Toxoplasma gondii was 
positive in the lymph node specimens. The patient un-
derwent chemotherapy according to oncologist recom-
mendations. Two years follow up has shown no relapse or 
major complications.
3. Discussion
ALCL has known as a distinct subset of non- Hodgkin 
lymphoma, accounted for 10% - 15% and 2% - 8% of non-
Hodgkin lymphomas in children and adults, respectively 
(1, 3). It had two major systemic and primary cutaneous 
forms.
Primary cutaneous ALCL accounts for approximately 9% 
of cutaneous lymphomas and arises de novo in the skin. 
Patients with this forms of ALCL are generally older than 
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patients with the systemic form of ALCL with a median 
age of approximately 60 years (3, 6). Its major difference 
from systemic type is the absence of the ALK protein (6).
The ALK protein is a fusion protein produced by a genet-
ic translocation most commonly t (2; 5) involving the ALK 
gene on chromosome 2 and the nucleophosmine (NPM) 
gene on chromosome 5(3). ALK expression is present in 
30% - 60% of ALCLs and but is not present in normal lym-
phoid tissues (7).
Systemic ALCL is more frequent than primary cutane-
ous form and more common in the first three decades of 
life. Although systemic type could involve lymph nodes 
in more than 90% of the time, extra nodal involvement 
including skin (25%), lung (10%), bone (17%) and liver (8%) 
is also frequent (3).
Systemic type with cutaneous spread must be dis-
tinguished from Primary cutaneous ALCL because the 
former is an aggressive disease which necessitates mul-
tiagent systemic chemotherapy. Conversely primary cu-
taneous ALCL has 90% - 100% five years survival so immu-
nostainig for ALK should be performed (7).
The diagnosis of our patient was ALK+ systemic ALCL ac-
cording to the positivity of tumor cells for ALK protein.
Natural killer cells are considered to play a role in the 
regulation of hematopoietic cells’ activity in thymus 
and bone marrow, so infection with Toxoplasma gondii 
might decrease host immune response against tumor 
cell growth and predispose the patient to non-Hodgkin 
lymphoma (8, 9). Some studies on mice infected with Toxoplasma gondii showed decreased natural killer cell 
activity and changed thymic architecture. On the other 
hand toxoplasmosis (primary infection or secondary re-
activation of latent infection) might be a complication 
of lymphoma, especially Hodgkin lymphoma, following 
impaired cell immunity (10). So, existence of an occult 
lymphoma before the appearance of signs and symp-
toms of toxoplasmosis is another explanation for our 
patient’s presentation, although the normal lymph node 
biopsy, chest x-ray and abdominal ultra sound examina-
tion results of ten months before presentation of ALCL 
are against this hypothesis. Anyhow whether toxoplas-
mosis is a predisposing factor for lymphoma needs more 
investigations.
4. Conclusions 
Necrotizing skin ulcer could be one of the manifesta-
tions of malignancies in children. In addition, accord-
ing to our report and few other studies, there might be 
a role for toxoplasma infection to cause some malignan-
cies such as lymphoma so it is suggested to set up some 
studies to compare the rate of toxoplasma infection in 
patients suffered from lymphoma and normal popula-
tion in children.
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